MedPath
FDA Approval

Radiogardase

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
October 7, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Prussian blue(500 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments4

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Haupt Pharma Wuelfing GmbH

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

333274975

Ostthüringische Materialprüfgesellschaft für Textil- und Kunststoffe mbH

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

332338250

SGS INSTITUT FRESENIUS GmbH

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

341259550

Laborchemie Apolda GmbH

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

Heyl Chem.-pharm. Fabrik GmbH & Co. KG

331821462

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Radiogardase

Product Details

NDC Product Code
58060-002
Application Number
NDA021626
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 7, 2021
GELATINInactive
Code: 2G86QN327LClass: IACTQuantity: 83.12 mg in 1 1
WATERInactive
Code: 059QF0KO0RClass: IACTQuantity: 14.21 mg in 1 1
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACTQuantity: 0.15 mg in 1 1
Code: TLE294X33AClass: ACTIBQuantity: 500 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACTQuantity: 38 mg in 1 1
INDIGOTINDISULFONATE SODIUMInactive
Code: D3741U8K7LClass: IACTQuantity: 0.67 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath